North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030


The North America Androgenetic Alopecia Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).

The US market dominated the North America Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,143.2 Million by 2030. The Canada market is experiencing a CAGR of 9.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.3% during (2023 - 2030).

One of the primary drivers of adoption in the androgenetic alopecia market is the growing awareness and acceptance of hair loss as a common condition. As public understanding of androgenetic alopecia expands, more individuals seek information and solutions to address their concerns. This increased awareness has led to a shift in societal attitudes, with a greater acceptance of seeking medical or cosmetic interventions for hair loss. A decreasing stigma is associated with seeking cosmetic enhancements for both men and women. As societal norms change, individuals are more open to exploring various interventions to address their hair loss concerns, contributing to the overall adoption of treatments within the market.

Media and social media platforms are crucial in shaping beauty standards and influencing individual choices. Celebrity endorsements and testimonials regarding hair restoration treatments have become common, impacting the adoption rates within the market. High-profile figures openly discussing their experiences with hair loss treatments contribute to the normalization of seeking such interventions. Individuals from diverse locations can access information about different treatment options, connect with specialists, and choose interventions that suit their preferences and needs.

As per the International Trade Administration (ITA), in the first half of 2022, the Canadian cosmetics industry was the fastest-growing industry in the country. In 2022, Canada’s personal care and beauty sector earned around $11 billion in revenue. Advancements in technology, such as laser therapy, platelet-rich plasma (PRP) treatments, and robotic hair transplantation, are gaining popularity in Canada. Celebrity endorsements, media representation, and the influence of social media contribute to shaping beauty standards and aesthetic preferences in Canada. Also, ITA estimates by 2024, cosmetic industry revenue is anticipated to increase by 1.45% yearly to USD 1.8 billion. Hence, the factors mentioned above will drive the regional market growth.

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Cipla Limited
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC (GSK)
  • Sun Pharmaceuticals Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Aurobindo Pharma Limited
  • Pfizer, Inc.
  • Lutronic Co., Ltd.
  • Viatris Inc.
  • Eli Lilly and Company
North America Androgenetic Alopecia Market Report Segmentation

By Treatment
  • Pharmaceuticals
  • Devices
By Gender
  • Male
  • Female
By Sales Channel
  • Prescriptions
  • OTC
By End-use
  • Dermatology Clinics
  • Homecare Settings
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Androgenetic Alopecia Market, by Treatment
1.4.2 North America Androgenetic Alopecia Market, by Gender
1.4.3 North America Androgenetic Alopecia Market, by Sales Channel
1.4.4 North America Androgenetic Alopecia Market, by End-use
1.4.5 North America Androgenetic Alopecia Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Androgenetic Alopecia Market, By Treatment
4.1 North America Pharmaceuticals Market, By Country
4.2 North America Devices Market, By Country
Chapter 5. North America Androgenetic Alopecia Market, By Gender
5.1 North America Male Market, By Country
5.2 North America Female Market, By Country
Chapter 6. North America Androgenetic Alopecia Market, By Sales Channel
6.1 North America Prescriptions Market, By Country
6.2 North America OTC Market, By Country
Chapter 7. North America Androgenetic Alopecia Market, By End-use
7.1 North America Dermatology Clinics Market, By Country
7.2 North America Homecare Settings Market, By Country
Chapter 8. North America Androgenetic Alopecia Market, By Country
8.1 US Androgenetic Alopecia Market
8.1.1 US Androgenetic Alopecia Market, By Treatment
8.1.2 US Androgenetic Alopecia Market, By Gender
8.1.3 US Androgenetic Alopecia Market, By Sales Channel
8.1.4 US Androgenetic Alopecia Market, By End-use
8.2 Canada Androgenetic Alopecia Market
8.2.1 Canada Androgenetic Alopecia Market, By Treatment
8.2.2 Canada Androgenetic Alopecia Market, By Gender
8.2.3 Canada Androgenetic Alopecia Market, By Sales Channel
8.2.4 Canada Androgenetic Alopecia Market, By End-use
8.3 Mexico Androgenetic Alopecia Market
8.3.1 Mexico Androgenetic Alopecia Market, By Treatment
8.3.2 Mexico Androgenetic Alopecia Market, By Gender
8.3.3 Mexico Androgenetic Alopecia Market, By Sales Channel
8.3.4 Mexico Androgenetic Alopecia Market, By End-use
8.4 Rest of North America Androgenetic Alopecia Market
8.4.1 Rest of North America Androgenetic Alopecia Market, By Treatment
8.4.2 Rest of North America Androgenetic Alopecia Market, By Gender
8.4.3 Rest of North America Androgenetic Alopecia Market, By Sales Channel
8.4.4 Rest of North America Androgenetic Alopecia Market, By End-use
Chapter 9. Company Profiles
9.1 Cipla Limited
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 GlaxoSmithKline PLC (GSK)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Sun Pharmaceuticals Industries Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Dr. Reddy’s Laboratories Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Aurobindo Pharma Limited
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trails and Approvals:
9.7.6 SWOT Analysis
9.8 Lutronic Co., Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Viatris, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Eli Lilly And Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings